{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:02:37Z","timestamp":1777557757328,"version":"3.51.4"},"reference-count":110,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Technology & Therapeutics"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1089\/dia.2013.0281","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T09:27:32Z","timestamp":1381915652000},"page":"901-908","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":12,"title":["Use of Non-Insulin Therapies for Type 1 Diabetes"],"prefix":"10.1177","volume":"15","author":[{"given":"Satish K.","family":"Garg","sequence":"first","affiliation":[{"name":"University of Colorado Denver"},{"name":"University of Colorado Denver"},{"name":"Editor-in-Chief, Diabetes Technology & Therapeutics."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron W.","family":"Michels","sequence":"additional","affiliation":[{"name":"University of Colorado Denver"},{"name":"University of Colorado Denver"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viral N.","family":"Shah","sequence":"additional","affiliation":[{"name":"University of Colorado Denver"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"key":"e_1_3_1_2_2","unstructured":"National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. 2011. www.cdc.gov\/diabetes\/pubs\/pdf\/ndfs_2011.pdf. 2013 August 16."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2011.12.001"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60591-7"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2420"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2011.583234"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-61-2-247"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1012384"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-5-896"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.36.2.136"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2005.00561.x"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-013-0314-z"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071583"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1636-9"},{"key":"e_1_3_1_17_2","unstructured":"REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)Identifier NCT01483560http:\/\/clinicaltrials.gov\/show\/NCT01483560. 2013 September 13."},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041001"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0086-y"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.1990"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.04.012"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1235"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1375.056"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.1.154"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200525090-00003"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.7.1058"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.11.008"},{"key":"e_1_3_1_28_2","first-page":"7","article-title":"Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes","volume":"13","author":"Juntti-Berggren L","year":"2000","unstructured":"Juntti-Berggren L, , Pigon J, , Hellstr\u00f6m P, , Holst JJ, , Efendic S. Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes. Diabetes Nutr Metab, 2000; 13:7\u201312.","journal-title":"Diabetes Nutr Metab"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0742-3071.2001.00563.x"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K11E-129"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1902.sp000920"},{"key":"e_1_3_1_32_2","first-page":"620","article-title":"Sur les possibilit\u00e9s d'un traitement du diab\u00e8te par l'incr\u00e9tine","volume":"12","author":"La Barre J","year":"1932","unstructured":"La Barre J. Sur les possibilit\u00e9s d'un traitement du diab\u00e8te par l'incr\u00e9tine. Bull Acad R Med Belg, 1932; 12:620\u2013634.","journal-title":"Bull Acad R Med Belg"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI104130"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-24-10-1076"},{"key":"e_1_3_1_35_2","unstructured":"Food and Drug Administration. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2007\/022044TOC.cfm. 2013 August 30."},{"key":"e_1_3_1_36_2","unstructured":"Food and Drug Administration. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2011\/201280Orig1s000TOC.cfm. 2013 August 30."},{"key":"e_1_3_1_37_2","unstructured":"Food and Drug Administration. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2009\/022350s000TOC.cfm. 2013 August 30."},{"key":"e_1_3_1_38_2","unstructured":"Food and Drug Administration. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2009\/021919_byetta_toc.cfm. 2013 August 30."},{"key":"e_1_3_1_39_2","unstructured":"Food and Drug Administration. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/022341s000TOC.cfm. 2013 August 30."},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00030.2002"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035801"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00700.2009"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.19.6.580"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1169"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2440"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0096"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0330"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.01.020"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0773"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.04.006"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03331.x"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP12100.OR"},{"key":"e_1_3_1_53_2","first-page":"99","article-title":"Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes","volume":"7","author":"Giampietro O","year":"2013","unstructured":"Giampietro O, , Giampietro C, , Bartola LD, , Masoni MC, , Matteucci E. Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes. Drug Des Dev Ther, 2013; 7:99\u2013104.","journal-title":"Drug Des Dev Ther"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-12-3"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.602964"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.09.004"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307684"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305889"},{"key":"e_1_3_1_59_2","unstructured":"Liraglutide Effect and Action in Diabetes. Evaluation of Cardiovascular Outcome Results\u2014A Long Term Evaluation (LEADER)Identifier NCT01179048http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01179048. 2013 September 13."},{"key":"e_1_3_1_60_2","unstructured":"Sitagliptin Cardiovascular Outcome Study (0431-082 AM1) (TECOS)Identifier NCT00790205http:\/\/clinicaltrials.gov\/ct2\/show\/NCT007902052013 September 13."},{"key":"e_1_3_1_61_2","unstructured":"CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients with Type 2 DiabetesIdentifier NCT01243424http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01243424. 2013 September 13."},{"key":"e_1_3_1_62_2","first-page":"1970","article-title":"Exenatide and rare adverse events","volume":"358","author":"Ahmad SR","year":"2008","unstructured":"Ahmad SR, , Swann J. Exenatide and rare adverse events. N Engl J Med, 2008; 358:1970\u20131971.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.018"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1591-5"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.2720"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1686"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2013.0177"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0520"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365517109090668"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.509"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01511.x"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0064-9"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.812632"},{"key":"e_1_3_1_74_2","unstructured":"Safety Tolerability. Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy VolunteersIdentifier NCT00836225http:\/\/clinicaltrials.gov\/ct2\/show\/NCT008362252013 September 13."},{"key":"e_1_3_1_75_2","unstructured":"Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 WeeksIdentifier NCT00297180http:\/\/clinicaltrials.gov\/ct2\/show\/NCT002971802013 September 13."},{"key":"e_1_3_1_76_2","unstructured":"An Efficacy Safety Tolerability Study for TA-7284 in Patients With Type 2 DiabetesIdentifier NCT01022112http:\/\/clinicaltrials.gov\/ct2\/show\/NCT010221122013 September 13."},{"key":"e_1_3_1_77_2","unstructured":"Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes MellitusIdentifier NCT01029704http:\/\/clinicaltrials.gov\/ct2\/show\/NCT010297042013 September 13."},{"key":"e_1_3_1_78_2","unstructured":"A Safety Tolerability Pharmacokinetics Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes MellitusIdentifier NCT00963768http:\/\/clinicaltrials.gov\/ct2\/show\/NCT009637682013 September 13."},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-4-201308200-00007"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60216-5"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.58"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1472"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.03.007"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01569.x"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.2174\/1874104501105010078"},{"key":"e_1_3_1_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.10.009"},{"key":"e_1_3_1_87_2","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2013.05.2635"},{"key":"e_1_3_1_88_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-837662"},{"key":"e_1_3_1_89_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0330"},{"key":"e_1_3_1_90_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01304.x"},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.2174\/187221411794351842"},{"key":"e_1_3_1_92_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0064"},{"key":"e_1_3_1_93_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009128.pub2"},{"key":"e_1_3_1_94_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01320.x"},{"key":"e_1_3_1_95_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2013.00051"},{"key":"e_1_3_1_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0074-7"},{"key":"e_1_3_1_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2010.03.006"},{"key":"e_1_3_1_98_2","unstructured":"Effects of Metreleptin in Type 1 Diabetes MellitusIdentifier NCT01268644http:\/\/clinicaltrials.gov\/show\/NCT01268644. 2013 August 29."},{"key":"e_1_3_1_99_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21094"},{"key":"e_1_3_1_100_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0410-5"},{"key":"e_1_3_1_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.09.007"},{"key":"e_1_3_1_102_2","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v2.i12.217"},{"key":"e_1_3_1_103_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1720"},{"key":"e_1_3_1_104_2","unstructured":"Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes (REPAIR-T1D)Identifier NCT01155284http:\/\/clinicaltrials.gov\/ct2\/show\/NCT011552842013 August 30."},{"issue":"1","key":"e_1_3_1_105_2","first-page":"S-1","article-title":"Impact of insulin delivery devices in diabetes care","volume":"12","author":"Garg SK","year":"2010","unstructured":"Garg SK. Impact of insulin delivery devices in diabetes care. Diabetes Technol Ther, 2010; 12,Suppl 1:S-1\u2013S-4.","journal-title":"Diabetes Technol Ther"},{"key":"e_1_3_1_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)80085-Z"},{"issue":"1","key":"e_1_3_1_107_2","first-page":"S-1","article-title":"How basal insulin analogs have changed diabetes care","volume":"13","author":"Garg SK","year":"2011","unstructured":"Garg SK, , Moser E. How basal insulin analogs have changed diabetes care. Diabetes Technol Ther, 2011; 13,Suppl 1:S-1\u2013S-4.","journal-title":"Diabetes Technol Ther"},{"key":"e_1_3_1_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.01.027"},{"key":"e_1_3_1_109_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2013.0169"},{"key":"e_1_3_1_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1134-3230(10)62002-9"},{"key":"e_1_3_1_111_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP.16.5.730"}],"container-title":["Diabetes Technology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/dia.2013.0281","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2013.0281","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2013.0281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:19:36Z","timestamp":1777400376000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/dia.2013.0281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":110,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1089\/dia.2013.0281"],"URL":"https:\/\/doi.org\/10.1089\/dia.2013.0281","relation":{},"ISSN":["1520-9156","1557-8593"],"issn-type":[{"value":"1520-9156","type":"print"},{"value":"1557-8593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}